Delivery Order SPE2DE24D0021-SPE2D626F14CD
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $27,478.56 fixed-price delivery order by the Department of Defense Medical Supply Chain on January 12, 2026, for PCR IV 1st Strain Superscript 50 reaction kits, with performance completion expected by January 27, 2026. The contract was issued without set-aside designation, indicating open competition. This delivery order represents a child contract under a larger procurement vehicle, leveraging Fisher Scientific's established position as a...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract by the Department of Defense Medical Supply Chain for a Kit RT PCR RNA DNA Polymer with a ceiling value of $1,604.00. The award was issued on October 30, 2025, with an ultimate completion date of November 14, 2025. This fixed-price contract with economic price adjustment represents a child contract under a larger procurement vehicle and involves no set-aside designation, indicating competition in an open federal...
- Fisher Scientific Company L.L.C. was awarded a $4,010.00 fixed-price delivery order with economic price adjustment authority by the Department of Defense's Medical Supply Chain on December 30, 2025, for RT-PCR RNA/DNA polymer kit components with ultimate completion by January 14, 2026. The award, executed through a child contract arrangement at the Pittsburgh, Pennsylvania location, represents a routine procurement of specialized molecular diagnostic supplies supporting federal healthcare and...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $10,700.70 by the Department of Defense's Medical Supply Chain on January 15, 2026, for kit real-time polymerase chain reaction DNA polymer single-step superscript III platen supplies. The contract, which is not set-aside designated, represents a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of February 4, 2026. This award is a child contract issued under a...
- Fisher Scientific Company L.L.C. has been awarded a fixed-price delivery order valued at $6,420.42 for one kit of real-time polymerase chain reaction (PCR) DNA primer with single-step substrate and caption plates, to be delivered to Pittsburgh, Pennsylvania. The contract was awarded on August 28, 2025, with an ultimate completion date of September 17, 2025. This delivery order represents a child contract with no set-aside designation, awarded through open competition to support the Medical...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $2,748.00 for the provision of RT PCR RNA test kits with built-in hot start gel from the Department of Defense's Medical Supply Chain. The contract, awarded on November 6, 2025, is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of November 21, 2025. This delivery order represents a child contract with no set-aside designation, indicating open competition in the...
- Fisher Scientific Company L.L.C. received a delivery order valued at $28,623.50 from the Department of Defense Medical Supply Chain for System PCR IV 1st Strain Superscript 50 Reaction kits, with an ultimate completion date of November 20, 2025. This fixed-price contract with economic price adjustment was awarded on November 5, 2025, with no set-aside designation, indicating open competition. The supplies will be delivered to Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $24,919.70 by the Department of Defense's Medical Supply Chain on March 11, 2025, for the provision of AGPATH-ID One-Step RT-PCR test kits (quantity 100). This fixed-price delivery order with economic price adjustment is a child contract operating under a larger procurement vehicle and carries an ultimate completion date of March 18, 2025. The contract was awarded without set-aside designation, indicating open competition....
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,560.56 on December 18, 2025, for the supply of a PCR DNA polymerase kit, single-step substrate, and a 3-well plate configuration. This fixed-price delivery order with economic price adjustment serves the Department of Defense's Medical Supply Chain and is scheduled for completion by January 12, 2026. The contract was awarded without set-aside designation, indicating open competition. Performance will occur at the...
- Fisher Scientific Company L.L.C. received a $4,178.20 fixed-price delivery order from the Department of Defense's Medical Supply Chain on January 10, 2026, for Kit RT PCR DNA Polymer 1 Step Superscipt3 Platin, with final delivery required by January 29, 2026. The award was issued without set-aside designation, indicating open competition. This delivery order represents a child contract under a larger indefinite delivery vehicle, enabling the Department of Defense to procure specialized molecular...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F14CDDelivery Order
Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $12,323.95 by the Department of Defense's Medical Supply Chain for the provision of a PCR (polymerase chain reaction) kit for 1 mL DNA multiplex testing. This delivery order, issued on January 18, 2026, with an ultimate completion date of January 27, 2026, represents a child contract under a larger procurement vehicle. The award carries no set-aside designation, indicating Fisher Scientific competed in an open procurement environment. The place of performance is located in Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of business, and the contract utilizes fixed-price pricing with economic price adjustment provisions to account for potential cost fluctuations during performance. This delivery order aligns with Fisher Scientific's established role as a critical federal supplier of laboratory and diagnostic equipment to the Department of Defense and other federal health agencies. The company's extensive federal contract portfolio demonstrates its capacity to reliably deliver specialized diagnostic test kits and laboratory supplies to military medical facilities and healthcare operations. The contract's brief performance period and focused scope reflect routine procurement of diagnostic reagents supporting molecular biology and infectious disease testing capabilities within DoD's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 1/17/26 |